SuperworthDianthus Therapeutics shares outstanding DNTH
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 56M
- On a year earlier
- +56.4%
- more shares
Dianthus Therapeutics had 56M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 56.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 45M | +27% |
| FY2024 | 35.4M | +139% |
| FY2023 | 14.8M | +1594% |
| FY2022 | 874.5K | −76% |
| FY2021 | 3.7M | +22% |
| FY2020 | 3M | +24% |
| FY2019 | 2.4M | +18% |
| FY2018 | 2.1M | +1382% |
| FY2017 | 140K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 56M | +56% | |
| Q1 FY26 | 48M | +34% | |
| Q4 FY25 | 45M | +27% | |
| Q3 FY25 | 37.8M | +10% | |
| Q2 FY25 | 35.8M | +5% | |
| Q1 FY25 | 35.8M | +39% | |
| Q4 FY24 | 35.4M | +139% | |
| Q3 FY24 | 34.2M | +776% | |
| Q2 FY24 | 34.2M | +3812% | |
| Q1 FY24 | 25.7M | +2834% | |
| Q4 FY23 | 14.8M | +1594% | |
| Q3 FY23 | 3.9M | +347% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Dianthus Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.